ライフサイエンスコーパス: postmenstrual

1 eyes, 23.1%); persistent ROP at an advanced postmenstrual age (4 eyes, 30.8%); and/or vitreous hemor

2 se once daily in premature infants >38 weeks postmenstrual age (born prematurely but chronologically

3 irth weight infants who survived to 38 weeks postmenstrual age (n = 122) and a control group of 16 he

4 mg/kg/dose twice daily in infants <38 weeks postmenstrual age (n=8) resulted in oseltamivir carboxyl

5 The mean level of IGFBP3 at 30-35 weeks postmenstrual age (PMA) for infants with proliferative R

6 es by certified imagers starting at 32-weeks postmenstrual age (PMA).

7 he rate of survival without BPD at 36 weeks' postmenstrual age (PMA).

8 was performed at 31-36 weeks and 37-42 weeks postmenstrual age (PMA).

9 a and by use of supplemental oxygen at 36 wk postmenstrual age (PMA).

10 increased risk for death or BPD at 36 weeks' postmenstrual age (risk ratio, 1.21; 95% CI, 1.10-1.32)

11 - death or chronic lung disease at 36 weeks' postmenstrual age - occurred in significantly fewer infa

12 n tensor imaging (DTI) scans, early in life (postmenstrual age [PMA] = 32.3 weeks) and at term-equiva

13 ung-preterm infants (imaged from 30-36 weeks postmenstrual age [PMA]); 78% of term-aged preterm infan

14 ates (1 girl and 3 boys; mean age, 38 weeks' postmenstrual age [range, 34-43 weeks]) with various sta

15 monary dysplasia or death prior to 36 weeks' postmenstrual age affects approximately 45% of VLBW infa

16 low-risk infants were examined at 37 weeks' postmenstrual age and followed up only if ROP was presen

17 h or bronchopulmonary dysplasia at 36 weeks' postmenstrual age and respiratory morbidity at 1 year of

18 uated, 72 were female (51.8%); the mean (SE) postmenstrual age at baseline was 41.5 (0.27) weeks.

19 Mean gestational age, birth weight, postmenstrual age at initial treatment, and follow-up pe

20 Targeting lower saturations reduced the postmenstrual age at last use of oxygen therapy (adjuste

21 r TBSS group comparisons based on increasing postmenstrual age at scan.

22 rly PN improved weight at discharge or 36 wk postmenstrual age by 14.9 g (5.3, 24.5 g) (observational

23 gen/RS at each week between 34 and 44 weeks' postmenstrual age indicated that the predictive ability

24 monary dysplasia or death before 36 weeks of postmenstrual age occurred in 52.3% of the infants in th

25 ive-pressure support or until they reached a postmenstrual age of 32 weeks 0 days.

26 iagnosed by the need for oxygen therapy at a postmenstrual age of 36 weeks, need for mechanical venti

27 ndardized oxygen-saturation monitoring, at a postmenstrual age of 36 weeks.

28 ember 2006 and August 2010 and survived to a postmenstrual age of 36 weeks.

29 Postmenstrual age of the mother at the time of examinati

30 itoring in selected infants), at 36 weeks of postmenstrual age or discharge home, whichever occurred

31 All infants who were 37 weeks postmenstrual age or older and stable were eligible for

32 primary outcome was death before 36 weeks of postmenstrual age or survival with bronchopulmonary dysp

33 Forty-two subjects from 31 weeks postmenstrual age to 1.5 years were imaged with a portab

34 ut bronchopulmonary dysplasia at 36 weeks of postmenstrual age was 43.9 percent in the group receivin

35 y of premature infants starting at 32 weeks' postmenstrual age was conducted.

36 Healthy infants born between 37 and 42 weeks postmenstrual age were imaged with hand-held spectral-do

37 pulmonary dysplasia/death rates at 36 weeks' postmenstrual age were similar (27.1% vs 35.6%; P = .32)

38 robehavioral examinations at term equivalent postmenstrual age were used to assess cerebral structure

39 infants, the rate of survival to 36 weeks of postmenstrual age without bronchopulmonary dysplasia did

40 ased solely on oxygen dependence at 36 weeks postmenstrual age without objective measurements of stru

41 first study-related eye examination (median postmenstrual age, 33 weeks; range, 29-40 weeks) who und

42 By 36 weeks' postmenstrual age, 59 of the 405 infants (15 percent) in

43 ssessment of preterm infants until 64 weeks' postmenstrual age, after which the WHO Child Growth Stan

44 300 eyes); 143 infants survived to 54 weeks' postmenstrual age, and the 7 infants who died were not i

45 need for supplemental oxygen at 36 weeks of postmenstrual age, as compared with 47 percent of those

46 , we recruited infants younger than 60 weeks postmenstrual age, born at greater than 26 weeks' gestat

47 ome was a composite of death after 36 weeks' postmenstrual age, motor impairment, cognitive or langua

48 ly preterm infants who survived to 36 weeks' postmenstrual age, prolonged hypoxemic episodes during t

49 ed bronchopulmonary dysplasia at 36 weeks of postmenstrual age, the need for systemic glucocorticoid

50 ortality and moderate/severe BPD at 36 weeks postmenstrual age.

51 olitis, or late-onset sepsis) by 36 weeks of postmenstrual age.

52 d with risk for BPD or death before 36 weeks postmenstrual age.

53 s death, moderate, or severe BPD at 36 weeks postmenstrual age.

54 rowth Standards for term babies by 64 weeks' postmenstrual age.

55 combined risk for death or BPD at 36 weeks' postmenstrual age.

56 f which 1534 infants died prior to 36 weeks' postmenstrual age.

57 tinuous supplemental oxygen use at 36 weeks' postmenstrual age.

58 re pooled from study sites and stratified by postmenstrual age.

59 coherence tomography imaging at 37-42 weeks postmenstrual age.

60 rimary outcome was death or BPD at 36 weeks' postmenstrual age.

61 ith abnormalities evident by term-equivalent postmenstrual age.

62 4 hours after birth until at least 36 weeks' postmenstrual age.

63 ll infants were evaluated at term-equivalent postmenstrual age.

64 l imaging in both eyes starting at 32 weeks' postmenstrual age.

65 eyes requiring retreatment before 54 weeks' postmenstrual age.

66 reterm infants aged between 30 and 55 weeks' postmenstrual age.

67 (soy) emulsion without DHA until 36 weeks of postmenstrual age.

68 ut bronchopulmonary dysplasia at 36 weeks of postmenstrual age.

69 or bronchopulmonary dysplasia at 36 weeks of postmenstrual age.

70 y in 18 infants aged between 25 and 45 weeks postmenstrual age.

71 and 39 wk ("long-term ventilated") corrected postmenstrual age.

72 requiring supplemental oxygen at 36 weeks of postmenstrual age.

73 was defined as oxygen dependence at 36 weeks postmenstrual age.

74 s death or chronic lung disease at 36 weeks' postmenstrual age.

75 ler head circumference (P=0.04) at 36 weeks' postmenstrual age.

76 percent in the placebo group at 36 weeks of postmenstrual age.

77 d chronic lung disease or death at 36 weeks' postmenstrual age.

78 eeks' gestation underwent two MRIs at median postmenstrual ages 32 and 40 weeks that included structu

79 Study participants were monitored until postmenstrual ages of 36 to 40 weeks with pulse oximeter

80 equirement alone as the criterion at various postmenstrual ages were less predictive compared with th

81 ria based on respiratory status at different postmenstrual ages.

82 also blocked reepithelialization in both the postmenstrual endometrium and the mouse uterus after dec

83 variety of organisms differed from pre- and postmenstrual observations whether subjects were using t

84 ntial for endometrial neoangiogenesis during postmenstrual/postpartum repair.

85 the relevance of VEGF family members during postmenstrual repair, we have evaluated ligands, recepto

86 A history of depression, postmenstrual symptom levels, and other diagnostic varia

87 trual syndrome and determined the effects of postmenstrual symptom severity and depression history as

88 The design was stratified for severity of postmenstrual symptoms and history of major depression.

89 Subjects with higher postmenstrual symptoms before treatment remained more sy

90 Higher levels of postmenstrual symptoms limit treatment response and are

91 olony counts at premenstrual versus mid- and postmenstrual visits for most microorganisms.

92 mood symptoms in the premenstrual versus the postmenstrual week); 5 of these depressed women and none

93 Eye size increased rapidly between 30 and 55 postmenstrual weeks and was comparable to that of term-b

94 investigating connectome development from 20 postmenstrual weeks to 5 years of age.

95 rush events in 10 preterm infants aged 32-36 postmenstrual weeks.